155 related articles for article (PubMed ID: 32736772)
21. Approach to chemotherapy-associated thrombosis.
Oppelt P; Betbadal A; Nayak L
Vasc Med; 2015 Apr; 20(2):153-61. PubMed ID: 25832603
[TBL] [Abstract][Full Text] [Related]
22. Thrombotic microangiopathies associated with drugs and bone marrow transplantation.
Moake JL; Byrnes JJ
Hematol Oncol Clin North Am; 1996 Apr; 10(2):485-97. PubMed ID: 8707765
[TBL] [Abstract][Full Text] [Related]
23. Thrombotic diseases in young women and the influence of oral contraceptives.
Lidegaard O
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S62-7. PubMed ID: 9753312
[TBL] [Abstract][Full Text] [Related]
24. ADAMTS13 Endopeptidase Protects against Vascular Endothelial Growth Factor Inhibitor-Induced Thrombotic Microangiopathy.
Erpenbeck L; Demers M; Zsengellér ZK; Gallant M; Cifuni SM; Stillman IE; Karumanchi SA; Wagner DD
J Am Soc Nephrol; 2016 Jan; 27(1):120-31. PubMed ID: 26038528
[TBL] [Abstract][Full Text] [Related]
25. Thrombotic microangiopathy related to anti-VEGF agents: intensive versus conservative treatment?
Izzedine H; Sène D; Hadoux J; Gharbi C; Bourry E; Massard C; Soria JC
Ann Oncol; 2011 Feb; 22(2):487-90. PubMed ID: 21278225
[No Abstract] [Full Text] [Related]
26. Thrombosis as a treatment complication in Hodgkin lymphoma patients: a comprehensive analysis of three prospective randomized German Hodgkin Study Group (GHSG) trials.
Borchmann S; Müller H; Hude I; Fuchs M; Borchmann P; Engert A
Ann Oncol; 2019 Aug; 30(8):1329-1334. PubMed ID: 31132094
[TBL] [Abstract][Full Text] [Related]
27. Sirolimus-related systemic thrombotic microangiopathy after renal transplantation.
Negrini S; Durrbach A; Becquemont L
Therapie; 2014; 69(2):175-7. PubMed ID: 24926637
[TBL] [Abstract][Full Text] [Related]
28. Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report.
Yamada R; Okawa T; Matsuo K; Suzuki M; Mori N; Mori K
BMC Nephrol; 2019 Jan; 20(1):14. PubMed ID: 30634936
[TBL] [Abstract][Full Text] [Related]
29. Drug-induced thromboembolic events in patients with malignancy.
Starakis I; Koutras A; Mazokopakis EE
Cardiovasc Hematol Disord Drug Targets; 2010 Jun; 10(2):94-102. PubMed ID: 20397970
[TBL] [Abstract][Full Text] [Related]
30. Chronic Microangiopathy Due to DCR-MYC, a Myc-Targeted Short Interfering RNA.
Miller AJ; Chang A; Cunningham PN
Am J Kidney Dis; 2020 Apr; 75(4):513-516. PubMed ID: 31866228
[TBL] [Abstract][Full Text] [Related]
31. Arterial Thrombosis in Cancer: Spotlight on the Neglected Vessels.
Canale ML; Bisceglia I; Lestuzzi C; Parrini I;
Anticancer Res; 2019 Sep; 39(9):4619-4625. PubMed ID: 31519559
[TBL] [Abstract][Full Text] [Related]
32. Adverse effects on hemostatic function of drugs used in hematologic malignancies.
Zakarija A; Kwaan HC
Semin Thromb Hemost; 2007 Jun; 33(4):355-64. PubMed ID: 17525893
[TBL] [Abstract][Full Text] [Related]
33. Thrombotic microangiopathy in allogeneic stem cell transplantation in childhood.
Erbey F; Bayram I; Kuskonmaz B; Yilmaz S; Cetin M; Uckan D; Tanyeli A
Exp Clin Transplant; 2010 Sep; 8(3):237-44. PubMed ID: 20716043
[TBL] [Abstract][Full Text] [Related]
34. Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib.
Bollée G; Patey N; Cazajous G; Robert C; Goujon JM; Fakhouri F; Bruneval P; Noël LH; Knebelmann B
Nephrol Dial Transplant; 2009 Feb; 24(2):682-5. PubMed ID: 19054798
[TBL] [Abstract][Full Text] [Related]
35. C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy.
Shah H; Chen H; Pan XZ; Metjian A; Brodsky RA; Braunstein EM; Chaturvedi S
Blood Adv; 2022 Dec; 6(23):6071-6074. PubMed ID: 35914225
[No Abstract] [Full Text] [Related]
36. A severe case of bevacizumab-induced thrombotic microangiopathy.
Bektas M; Samancı NS; Cokgezer S; Keskin D; Demirelli FH
J Oncol Pharm Pract; 2019 Oct; 25(7):1754-1757. PubMed ID: 30253727
[TBL] [Abstract][Full Text] [Related]
37. The Link Between Conventional and Novel Anti-Cancer Therapeutics with Thrombotic Microangiopathy.
Cervantes CE; Kant S; Atta MG
Drug Metab Lett; 2021; 14(2):97-105. PubMed ID: 34279209
[TBL] [Abstract][Full Text] [Related]
38. Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy.
Fakhouri F; Vercel C; Frémeaux-Bacchi V
Clin J Am Soc Nephrol; 2012 Dec; 7(12):2100-6. PubMed ID: 22879435
[TBL] [Abstract][Full Text] [Related]
39. Sunitinib-associated thrombotic microangiopathy: a significant risk.
Buckley FD; Preston G; Meiklejohn DJ; Adamson D
Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):515. PubMed ID: 24746506
[No Abstract] [Full Text] [Related]
40. THROMBOTIC MICROANGIOPATHY ASSOCIATED WITH OPANA ER INTRAVENOUS ABUSE A Case Report.
Jabr FI; Yu L
J Med Liban; 2016; 64(1):40-2. PubMed ID: 27169165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
